Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Clinical trial NCT00323804 · COMPLETED
Trial details
- NCT number
- NCT00323804
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.